Urinary Tract Infection (UTI) Clinical Trials

Urinary Tract Infection (UTI) Vaccine Clinical Trials 2025

Clinical trials for a urinary tract infection (UTI) vaccine and treatment are scheduled for December 2025. To register for a clinical trial, please visit this Clinical Trials Link. This GSK UTI vaccine candidate study is seeking participants in the United States, Argentina, Belgium, South Africa, and Spain.

Recurrent UTI Vaccine Information

Uromune™ (MV140) is a self-administered oral spray vaccine for recurrent urinary tract infections approved for adults in certain countries. A vaccination appointment can be requested at PassportHealth.